1.Evaluation of reliability of radiologic images posted on hospital websites for medical advertisements
Hee Sun KIM ; Bo Kyung JE ; Baek Hyun KIM ; Hyeong Sik AHN
Journal of the Korean Medical Association 2018;61(7):435-442
A medical advertisement can include media such as newspapers, magazines, and the Internet. Currently, the Internet is responsible for most medical advertising. Our purpose is to investigate the current status of radiologic images posted on hospitals' websites nationwide, and to evaluate the reliability of online medical advertisements using these images. I investigated the websites of all 1,450 hospitals and 290 oriental medicine clinics nationwide. Specific information on the radiologic images posted was recorded. In terms of body parts, musculoskeletal images account for 78% of the radiologic images on hospitals' websites and 98% of the images for oriental medicine clinics. The purposes for posting radiologic images are to explain the pathophysiology of diseases or the technique of surgical treatments, and to show the effects of hospital-specialized treatments. The most commonly used modalities of radiologic images are plain radiography and MR. More than 90% of the posted images have no source; 10% have no legends; and 5% to 7% have inappropriate legends. In terms of quality, only 60% of the radiologic images on hospitals' websites are rated as acceptable. Fifteen percent of the oriental medicine clinics posted the radiologic images without having a medical doctor on staff. Considering the results, I conclude that it is necessary to re-establish a system of pre-screening and post-evaluation for reviewing hospital websites, especially focusing on the radiologic images posted. Then we can prevent the inappropriate information from influencing or damaging public health, and set up healthy medical competition.
Diagnostic Imaging
;
Direct-to-Consumer Advertising
;
Health Information Systems
;
Human Body
;
Internet
;
Medicine, East Asian Traditional
;
Periodicals
;
Periodicals as Topic
;
Public Health
;
Radiography
3.PharmedOut.
Singapore medical journal 2008;49(4):363-365
5.FDA Premarket Pathways for Combination Products.
Chinese Journal of Medical Instrumentation 2022;46(4):355-360
Combination products face unique R&D, manufacturing, clinical, and regulatory challenges compared to individual devices, drugs, or biological products. Based on the interpretation of the relevant policies and the latest principles of combination products, this paper expounds the FDA's guidance, application trends, and application strategies for the pre-market pathways of combination products, with a view to providing relevant information for Chinese researchers and manufacturers when they start to entry the United States market.
Commerce
;
Consumer Product Safety
;
Direct-to-Consumer Advertising
;
United States
;
United States Food and Drug Administration